Cheryl Gault Sells $416K Worth of Rapport Therapeutics Shares
Cheryl Gault, COO of Rapport Therapeutics, sold 10,000 shares worth approximately $416,000 on June 30, 2026. The transaction aligns with her historical selling pattern and was executed during a period where the company's stock had risen by over 223% year-over-year.
Topics: executive activity SEC filing stock sale